Related Experiment Video

Updated: Apr 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1

Lixue Gu1, Weiming Sun1

  • 1The Department of Breast and Thyroid Surgery, The First Affiliate Hospital of Liaoning Medical University, Jinzhou, Liaoning 121000, China.

Biochemical and Biophysical Research Communications
|July 25, 2015
PubMed

Insights

MicroRNAs (miRNAs) suppress thyroid cancer cell invasion by targeting CARMA1. This study reveals miR-539 as a key regulator, inhibiting cancer cell migration and invasion through CARMA1 downregulation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of cellular functions.
  • Altered miRNA expression is linked to thyroid cancer development.
  • The specific role of miRNAs in thyroid cancer metastasis is not well understood.

Purpose of the Study:

  • To investigate the function of miR-539 in thyroid cancer metastasis.
  • To identify the molecular targets of miR-539 involved in cancer cell migration and invasion.
  • To elucidate the regulatory pathway of miR-539 in human thyroid cancer.

Main Methods:

  • Luciferase reporter assays to confirm miRNA-target interaction.
  • Cell migration and invasion assays.
  • Quantitative analysis of miRNA and CARMA1 expression in thyroid cancer cell lines and tissues.

Main Results:

  • miR-539 significantly inhibited thyroid cancer cell migration and invasion.
  • CARMA1 was identified as a direct target of miR-539, with miR-539 binding to its 3'-UTR.
  • CARMA1 overexpression or knockdown modulated the effects of miR-539 on cell motility.
  • miR-539 was downregulated, while CARMA1 was upregulated in thyroid cancer samples.

Conclusions:

  • miR-539 acts as a tumor suppressor in thyroid cancer by inhibiting cell migration and invasion.
  • The miR-539/CARMA1 axis represents a novel regulatory mechanism in thyroid cancer progression.
  • miR-539 targeting of CARMA1 offers potential therapeutic strategies for thyroid cancer metastasis.
Keywords:
CARMA1InvasionMicroRNA-539MigrationThyroid cancer

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K